Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt

EU orphan designation number: EU/3/09/647   
Active ingredient: (S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt
Indication: Treatment of chronic iron overload requiring chelation therapy
Sponsor: Shire Pharmaceutical Development Limited
1 Kingdom Street, Paddington, London W2 6BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/08/2009 Orphan designation EMEA/OD/008/09 (2009)6076 of 24/07/2009
01/03/2011 Change of name and/or address of sponsor EMEA/OD/008/09
02/08/2012 Transfer of orphan designation EMEA/OD/008/09/T/01 (2012)5532 of 27/07/2012
20/03/2018 Change of name and/or address of sponsor